Protocol summary

Study aim
Comparison of the skin effects of pretreatment preparation with chlorhexidine solution and povidone-iodine before rhinoplasty
Design
Clinical trial,two interventional group, blinded patients and the assesor, randomization, allocation proportion 1:1 on 42 patients. randomization is doing with exel soft ware RANDBETWEEN.
Settings and conduct
Patients are in two groups includig chlorhexine and povidone-iodine, and prepping 21persons with chlorhexidine and 21 persons with povidone-iodine before surgery. open rhinoplasty surgery is doing by one surgeon in noor surgical clinic. blinding is in two level: patients and the assesor.
Participants/Inclusion and exclusion criteria
Patients who are candidates for rhinoplasty surgery
Intervention groups
First intervention group: prepping the patient's face with chlorhexidine before surgery second intervention group: prepping the patient's face with povidone-iodine before surgery
Main outcome variables
Erythema; Itching

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20211121053135N1
Registration date: 2022-02-06, 1400/11/17
Registration timing: registered_while_recruiting

Last update: 2022-02-06, 1400/11/17
Update count: 0
Registration date
2022-02-06, 1400/11/17
Registrant information
Name
Hooshyar Abbasi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 83 3729 2254
Email address
hoshyar7ab@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-12-22, 1400/10/01
Expected recruitment end date
2022-02-20, 1400/12/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the skin effects of pretreatment preparation with chlorhexidine solution and povidone-iodine before rhinoplasty: a randomized clinical trial
Public title
Comparison of the skin effects of pretreatment preparation with chlorhexidine solution and povidone-iodine before rhinoplasty: a randomized clinical trial
Purpose
Other
Inclusion/Exclusion criteria
Inclusion criteria:
ASA I or II health status. The patient is ready to take part in the study and sign the testimonial.
Exclusion criteria:
History of underlying diseases affecting the wound healing process like systemic diseases(diabetes, high blood pressure, gastrointestinal system diseases, kidney disorders, heart and lung diseases) Current consumption of drugs, alcohol, opiums (consumption of any of these substances during the last month) Pregnant women Any allergies or Hypersensitivities to the drugs used in this study
Age
From 18 years old
Gender
Both
Phase
2
Groups that have been masked
  • Participant
  • Outcome assessor
Sample size
Target sample size: 42
Randomization (investigator's opinion)
Randomized
Randomization description
Random numbers are generated using Excel software by a statistician to do this. Four-digit codes are generated. A four digit code is allocated to each patient and the last digit on the right indicates the patient group. if the number obtained is odd(1,3,5,7,9), the patient is in the chlorhexidine group and if the number is even(0,2,4,6,8), the patient is in the povidone-iodine group Each of the generated codes is kept separately inside the envelope and the receptionist gives one of these envelopes to the patient before entering the operating room. Accordingly, the next patient code is not predictable. Based on the patient's code, the physician determines which treatments to implement, Only the physician who implements the intervention knows the code allocated to the patient, which after evaluating the outcome, based on thepatient's name, the information collected will be related to the assigned codes.
Blinding (investigator's opinion)
Double blinded
Blinding description
Blinding is performed in 2 levels including the patient and outcome assessor . As the irrigation with chlorhexidine and povidone-iodine is done while anesthesia , the patient is uninformed about the kind of intervention. Also the outcome assessor who is the dermatologist is uninformed about the kind of patients intervention. Therefore in this study both the patient and the outcome assessor are uninformed about the kind of patient intervention.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Kermanshah University of Medical Science
Street address
Mohamadi Ave., Amirkabir Blvd., Kermanshah Town
City
Kermanshah
Province
Kermanshah
Postal code
6714738178
Approval date
2022-01-29, 1400/11/09
Ethics committee reference number
IR.KUMS.REC.1400.754

Health conditions studied

1

Description of health condition studied
Urticaria
ICD-10 code
L50
ICD-10 code description
Urticaria

2

Description of health condition studied
Erythema
ICD-10 code
B08.3
ICD-10 code description
Erythema infectiosum [fifth disease]

3

Description of health condition studied
Acne
ICD-10 code
L70
ICD-10 code description
Acne

4

Description of health condition studied
Macula
ICD-10 code
ICD-10 code description
Macula

5

Description of health condition studied
Papula
ICD-10 code
ICD-10 code description
Papula

6

Description of health condition studied
Plaque
ICD-10 code
ICD-10 code description
Plaque

7

Description of health condition studied
Seborrheic dermatitis
ICD-10 code
L21
ICD-10 code description
Seborrheic dermatitis

8

Description of health condition studied
Perioral dermatitis
ICD-10 code
L71.0
ICD-10 code description
Perioral dermatitis

9

Description of health condition studied
Allergic contact dermatitis
ICD-10 code
L23
ICD-10 code description
Allergic contact dermatitis

10

Description of health condition studied
Itching
ICD-10 code
ICD-10 code description
Itching

11

Description of health condition studied
Burning
ICD-10 code
ICD-10 code description
Burning

12

Description of health condition studied
Scabbing
ICD-10 code
ICD-10 code description
Scabbing

Primary outcomes

1

Description
Initial outcome will be contain of erythema
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
Erythema will be studied on the basis of dermatologist opinion in this way: without, light, moderate and severe erythema.

2

Description
Initial outcome will be contain of itching
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
Itching will be studied on the basis of ten parts scale Visual Analogue Scale with asking from patient

Secondary outcomes

1

Description
Secondary outcome is containing of burning
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
Burning will be studied on the basis of ten parts scale Visual Analogue Scale with asking from patient

2

Description
Secondary outcome is containing of acne
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

3

Description
Secondary outcome is containing of urticaria
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

4

Description
Secondary outcome is containing of macula
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

5

Description
Secondary outcome is containing of papula
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

6

Description
Secondary outcome is containing of allergic contact dermatitis
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

7

Description
Secondary outcome is containing of perioral dermatitis
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

8

Description
Secondary outcome is containing of seborrheic dermatitis
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

9

Description
Secondary outcome is containing of plaque
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

10

Description
Secondary outcome is containing of scabbing
Timepoint
Patients will be studied about skin effects 3 days later, one week later and one month later after surgery.
Method of measurement
They will be studied on the basis of dermatologist opinion in 4 group: without, slight, moderate and severe events.

Intervention groups

1

Description
Intervention group (first): in chlorhexidine group, face prepping before surgery is done by 2% chlorhexidine.one surgeon operate them with open method and with midazolam induction, narcotic(fentanyl), atracurium(laxative) and propofol on the basis of person's per kilogram, and the surgery duration is about 1/5 hour and after that all the patients have tampon for 3 days, in addition to they have splint and mesh for one week on their nose.
Category
Prevention

2

Description
Intervention group(second): in povidone-iodine group, face prepping before surgery is done by 10% povidone-iodine. one surgeon operate them with open method and with midazolam induction, narcotic(fentanyl), atracurium(laxative) and propofol on the basis of person's per kilogram, and the surgery duration is about 1/5 hour and after that all the patients have tampon for 3 days, in addition to they have splint and mesh for one week on their nose.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Noor Specialized Surgical Center
Full name of responsible person
Dr Shahram Abbasabadi
Street address
Azadi Sq, Modares Ave, Kermanshah Town
City
Kermanshah
Province
Kermanshah
Postal code
6714738178
Phone
+98 83 3822 1300
Email
saba.ahmadi.den@gmail.com
Web page address
http://www.noortebclinic.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Zohreh Rahimi
Street address
school of dentistry,Shariati Ave
City
Kermanshah
Province
Kermanshah
Postal code
6714738178
Phone
+98 83 3724 8531
Email
saba.ahmadi.den@gmail.com
Web page address
http://dentistry-school.kums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Kermanshah University of Medical Science
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Hoshyar Abbasi
Position
Associated professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Moayed Ave, Sobhan Building
City
Kermanshah
Province
Kermanshah
Postal code
6714738178
Phone
+98 83 3729 2254
Email
hoshyar7ab@yahoo.com
Web page address
http://dentistry-school.kums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Hoshyar Abbasi
Position
Assiciated professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Moayed Ave, Sobhan Building
City
Kermanshah
Province
Kermanshah
Postal code
6714738178
Phone
+98 83 3729 2254
Email
hoshyar7ab@yahoo.com
Web page address
http://dentistry-school.kums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Hoshyar Abbasi
Position
Associated professor
Latest degree
Specialist
Other areas of specialty/work
Dentistry
Street address
Moayed Ave,Sobhan Building
City
Kermanshah
Province
Kermanshah
Postal code
6714738178
Phone
+98 83 3729 2254
Email
hoshyar7ab@yahoo.com
Web page address
http://dentistry-school.kums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...